Bruker Introduces Novel NMR Probe Technology for Biological Research

UTRECHT, The Netherlands, – July 11, 2022 – At the Euromar 2022 conference, Bruker showcases several innovations in advanced NMR probe technology to enable novel scientific research with much increased sensitivity for biological and materials research.

Bruker builds on the success of its 600 MHz MAS CryoProbe with two new 800 MHz CPMAS CryoProbes, including a BioSolids HCN 3.2 mm version with larger rotors, providing an 8-10 times signal-to-noise increase over conventional 3.2 mm MAS probes. A broadband 3.2 mm HX MAS Cryoprobe for materials science and quadrupolar nuclei enables the field of NMR 17O glycoanalysis and advances catalyst research. With sensitivity increases up to 10x, these new 800 MHz MAS Cryoprobes dramatically enhance biological, disease, and materials research.

800 MHz CPMAS CryoProbe

Bruker also announces a new 8 mm 15N TROSY 800 MHz Cryoprobe for investigations into larger, non-deuterated and intrinsically disordered proteins and intrinsically disordered protein regions. This new 8mm Cryoprobe provides 2x greater sensitivity than 5 mm 15N Cryoprobe detection, and 1.5x greater 13C sensitivity.

8mm 15N TROSY 800 MHz CryoProbe

Dr. Barbara Perrone, Product Manager at Bruker BioSpin 

We are pleased to offer the research community our latest NMR probe technology for solid-state and liquids NMR applications to advance research in stuctural and functional biology.

About Bruker Corporation

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit:

Customer Contact

Erin Thome
Product Marketing Manager
Bruker BioSpin
+41 79 355 65 95